Kangwei Pharma is one of the leading API Manufacturer of Norfloxacin in China initially established in 1995, with capacity of 1200mt/year. Norfloxacin(CAS NO. 70458-96-7) is a synthetic antibacterial agent that belongs to the class of fluoroquinolone antibiotics.Capital Ingredients is a fast-growing ingredient distributor with global vision focusing on Pharmaceutical, Flavors&Fragrances and Agrochemicals.

In order to further develop the global business especially in EU/related area, Kangwei Pharma has decided to appoint Capital Ingredients as the exclusive agency in the mentioned area and entrusted Capital Ingredients to apply for CEP.

The two parties have expected to build very promising co-operations by sharing mutual interests and combining respective advantages together.